Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) EPS (Basic) (2016 - 2023)

Historic EPS (Basic) for RedHill Biopharma (RDHL) over the last 12 years, with Q2 2023 value amounting to $0.09.

  • RedHill Biopharma's EPS (Basic) rose 64459.57% to $0.09 in Q2 2023 from the same period last year, while for Jun 2024 it was $4.34, marking a year-over-year increase of 319766.85%. This contributed to the annual value of $0.01 for FY2023, which is 10833.33% up from last year.
  • According to the latest figures from Q2 2023, RedHill Biopharma's EPS (Basic) is $0.09, which was up 64459.57% from -$0.05 recorded in Q1 2023.
  • In the past 5 years, RedHill Biopharma's EPS (Basic) ranged from a high of $0.09 in Q2 2023 and a low of -$0.37 during Q4 2021
  • Over the past 5 years, RedHill Biopharma's median EPS (Basic) value was $0.04 (recorded in 2019), while the average stood at $0.0.
  • Its EPS (Basic) has fluctuated over the past 5 years, first tumbled by 62857.14% in 2021, then soared by 64459.57% in 2023.
  • Over the past 5 years, RedHill Biopharma's EPS (Basic) (Quarter) stood at $0.03 in 2019, then surged by 133.33% to $0.07 in 2020, then tumbled by 628.57% to -$0.37 in 2021, then skyrocketed by 35.14% to -$0.24 in 2022, then skyrocketed by 137.5% to $0.09 in 2023.
  • Its last three reported values are $0.09 in Q2 2023, -$0.05 for Q1 2023, and -$0.24 during Q4 2022.